Sinks and Jackson take strong issue with a recent paper in EHP by Gulson et al. (1) on the biokinetics of lead transfer from maternal bone and other body lead stores to nursing infants via human breast milk. I wrote an invited Research Highlights paper (2) that accompanied and discussed the larger context and implications of Gulson et al. While Sinks and Jackson did not include my paper in their letter, their criticisms apply to a number of issues addressed in my artide.
Sinks and Jackson would have us believe Gulson et al. (1) were guilty of a public health heresy when the latter noted that there may be potential risks for nursing infants if lead intakes via breast milk are elevated because of elevated long-term maternal lead exposures. My quantitative lead exposure risk calculations for nursing infants in Table 1 make it clear that the potential impact of maternal lead burdens for nursing infants across a range of maternal blood lead (BPb) values is not a trivial matter.
The clearly indicated goals of Gulson et al. (1) were to examine and quantitatively characterize 1) in vivo lead movement in nursing mothers, specifically bone lead resorption during lactation and nursing, and 2) the toxicokinetic interplay between endogenous (bone) and exogenous (diet) lead in the bodies of these mothers as they relate to transport of maternal lead to breast milk and then to nursing infants. Their findings document that bone lead releases can contribute significantly to breast milk lead and ultimately to infant lead intake in terms of lead source fractional input. The breast milk study was A sensitivity analysis using various IEUBK modeling runs shows that the infant body lead burden at birth, from in utero accumulation via maternal lead exposures, is mainly expressed through estimated BPb values in the first 6 months of infant life, as compared to the second 6 months of infant life or as compared to exposure integrated over the entire first year of infant life. This is to be expected, given the relatively high biokinetic mobility of lead in the very young. However, it is precisely in the first 6 months of infant life that breast-feeding is done. Therefore, both breast milk lead and prior infant body lead burden are significant sources of lead in breast-feeding infants of mothers with elevated lead exposures. In essence, the only maternal BPb level that is in fact "safe" in terms of CDC Class III elevated infant BPb figures also approximates the CDC infant BPb action level of 10 pg/dl. In terms of the child action level of 10 pg/dl, a maternal BPb <10 pg/dl appears prudent.
The 1991 CDC statement on childhood lead poisoning (6) identified a BPb level of 10 pg/dl as being the body lead threshold associated with the earliest toxic effects in infants and toddlers. The CDC document also accepted the risk assessment premise that there is no known threshold for lead's subtle toxicity.
Sinks and Jackson argue that the most recent NHANES III, 1991-1994, indicates that there are no women in the United States who are likely to be nursing their infants and who have BPb values anywhere dose to the 40 pg/dl Sinks and Jackson daimed as permissible for nursing mothers. They cite some actual numbers noted in the NHANES III data tapes (7) . Such prevalence data are aggregated cluster sample depictions at a single time point of the U.S. population lead exposure picture, stratified by national socioeconomic and demographic strata. One cannot legitimately disaggregate such national depictions or "snapshots" to generate comparisons for individual community prevalences or to use actual BPb values contained in any particular statistical sampling cell in the aggregation process. Such limits are discussed in, among other things, the Executive Summary of the 1988 report to the U.S. Congress on childhood lead poisoning (8) The letter by Sinks and Jackson may be seen by some as another example of an overall CDC retreat from lead as a persisting child health issue. Needleman (9) noted an overall backpedaling in efforts and dedine in momentum to finally address the lead issue in a meaningful way by the federal government. All this raises a legitimate question among scientists and clinicians interested in lead: Is lead still considered to be a child health risk issue at the CDC or elsewhere in the federal government?
The actual content of new research should be understood before wholesale attacks on such research are launched. This is especially the case where complex research designs and equally complex results are at work. In those cases where breast milk does not contain worrisome lead concentrations bBreast milk feeding period, 0-6 months of age; matemal BPb levels are present at birth through 6 months.
cInfant Pb intake/day = 0.15 x maternal BPb (pg/dl) x 8 dl milk/day. dGeometric standard deviation = 1.6; GM infant BPb and percentages exceeding cutoffs obtained from graphic outputs expressed as probability density function histograms versus infant BPb and using age band WA 10-6 months of age). eCDC action level of 210 pg/dl. 
Response to Sinks and Jackson
We appreciate Sinks' and Jackson's interest in our article on lead in breast milk and would like to reinforce and clarify a couple of points. Paul Mushak has responded comprehensively to their letter, and we are in complete agreement with his response.
We agree wholeheartedly that "breast is best," and our low concentrations of lead in breast milk confirm this. Our abstract (1) was quite emphatic that Breast-fed infants are only at risk if the mother is exposed to high concentrations of contaminants either from endogenous sources such as the skeleton or exogenous sources.
Sinks and Jackson are dismissive of the use of lead isotopic ratios as not being "meaningful in establishing risk for lead poisoning." Perhaps this is true in the strict sense of risk assessment, but lead isotopic ratios are the only realistic method of determining the source of a mother's lead burden.
